Home › Products › Oncology › Palbico 125mg Tablet
Palbico 125mg Tablet
Salt Composition: PALBOCICLIB
- Manufacturer: PHARMACO INDUSTRIES PVT. LTD.
- Pack Size: 21 TABLET(s) IN A BOTTLE
- Dosage Form: TABLET
- Strength: 120MG
- Prescription Required
- Storage: Keep Palbico 125mg Tablet out of sight and reach of children. Store at 20°C to 25°C.
₹4125.00₹20625.00
Inclusive of all taxes
Product Introduction
Palbociclib, the active constituent in Palbico 125mg Tablet, is a cyclin-dependent kinase inhibitor used in anticancer therapy. It is indicated for treating hormone receptor-positive, human epidermal growth factor 2 negative advanced or metastatic breast cancer. The medication is administered in combination with certain other anticancer agents. Cancer occurs when cells multiply in an uncontrolled and abnormal manner.
Common side effects associated with Palbico 125mg Tablet include nausea, vomiting, diarrhoea, tiredness, hair loss, dry skin, rash, infections, nosebleed, decreased appetite, low blood cell counts, swelling of lips and mouth, changes in taste, dry eye, blurred vision, and increased tearing. Inform your doctor if any of these side effects persist or cause concern.
Inform your healthcare provider if you are allergic to palbociclib or any ingredients in this formulation. Before commencing treatment, it is essential to disclose to your doctor any signs of infections (fever, chills, or sore throat), liver disorders, kidney disorders, or intolerance to certain sugars. Consult your physician immediately if you experience dry cough, chest pain, or difficulty breathing, as these may indicate lung inflammation.
Inform your physician of all medicines you are taking, including supplements and herbal preparations, prior to starting treatment. Effective birth control should be used during treatment and for at least three weeks following the final dose. Palbico 125mg Tablet is not recommended for children and adolescents under 18 years of age.
Uses
Treatment of hormone receptor (HR)-positive, human epidermal growth factor 2 (HER2)-negative advanced or metastatic breast cancer.
How it works
Palbico 125mg Tablet works by blocking the protein called cyclin-dependent kinases 4 and 6, which are vital for the division and growth of cells. By blocking these proteins, this medication slows the growth and prevents the cancer cells from spreading.
How to Use
Take the Palbico 125mg Tablet exactly as prescribed by your doctor. Take this medication once a day at the same time with food. Swallow this capsule as a whole with a glass of water. Avoid crushing, breaking, or chewing the capsule.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Serious: Blood disorder (fever, chills, shortness of breath, weakness, bleeding, or bruising) Lung inflammation (chest pain, dry cough, or difficulty breathing) Common: Tiredness Hair loss Dry skin, rash Infections Low blood cell counts. Decreased of appetite Nausea, vomiting
Expert Tips
Avoid consuming grapefruit, grapefruit juice, and products containing St. John’s wort during treatment. Use effective birth control during treatment and for at least 3 weeks after the final dose (females) and 14 weeks after the final dose (males). This medicine may affect fertility. Discuss with your doctor if you have any fertility-related concerns before starting treatment. Your doctor may advise regular blood tests to monitor how the medicine is affecting your blood cells.
References
- Pfizer Limited, Electronic medicines compendium (emc), [Revised on June 2021] [ Accessed on 26 Nov 2022], https://www.medicines.org.uk/emc/files/pil.4449.pdf
- Pfizer Labs, US Food and Drug Administration, [Revised on March 2017] [ Accessed on 26 Nov 2022], https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207103s004lbl.pdf
- Neha S Mangini et al; Palbociclib: A Novel Cyclin-Dependent Kinase Inhibitor for Hormone Receptor-Positive Advanced Breast Cancer; The Annals of Pharmacotherapy; Published on Nov 2015; Accessed on 26/11/2022; https://pubmed.ncbi.nlm.nih.gov/26324355/
- Palbace; Pfizer; Revised on Oct 2021; Accessed on 26/11/2022; https://labeling.pfizer.com/ShowLabeling.aspx?id=14029
Safety Advice
Pregnancy: Unsafe It is not recommended to take Palbico 125mg Tablet during pregnancy as it can harm the unborn baby. Women with childbearing potential should use effective contraceptives during treatment and for at least three weeks after treatment.
Lungs: Consult Your Doctor You need to tell your physician if you have any lung disorders before taking Palbico 125mg Tablet, as this medication should be used with caution in kidney disorder patients.
Breastfeeding: Consult Your Doctor It is not recommended to take Palbico 125mg Tablet while breastfeeding as it is not known whether it passes into the breast milk. consult your healthcare provider before taking this capsule.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.